chartexchange

Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio

GlobeNewswire Inc. | Sep 18, 2026 8:50 AM EDT

Allowed claims cover compositions and methods for preventing or mitigating stress-induced behavioral responses

Read original article